Nuvectis Pharma Inc.

NVCT | NASDAQ

Price Alert Chart Builder DCF Calculator

$22.76

+$0.78 (+3.55%)

Sep 22, 2026, 1:35 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

TTM Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-28.87M	-28.27M	-27.57M	-26.41M	-22.97M	-21.02M	-19.85M	-20.26M	-22.06M	-23.19M	-22.9M	-22.81M	-22.59M	-20.39M	-19.23M	-14.72M	-13.45M	-15.82M	-12.89M	-10.63M	-5.96M	-23K
Interest Income	-110K	-26K	n/a	1.03M	904K	858K	847K	890K	961K	810K	637K	475K	259K	199K	149K	71K	10K	6K	4K	n/a	n/a	n/a
Pretax Income	-27.85M	-27.16M	-26.44M	-25.38M	-22.07M	-20.16M	-19M	-19.37M	-21.1M	-22.38M	-22.26M	-22.33M	-22.33M	-20.19M	-19.09M	-14.65M	-13.44M	-15.81M	-12.89M	-10.63M	-5.96M	-23K
Net Income	-27.85M	-27.16M	-26.44M	-25.38M	-22.07M	-20.16M	-19M	-19.37M	-21.1M	-22.38M	-22.26M	-22.33M	-22.33M	-20.19M	-19.09M	-14.65M	-13.44M	-15.81M	-12.89M	-10.63M	-5.96M	-23K
Selling & General & Admin	9.22M	9.69M	9.42M	8.84M	8.36M	7.08M	6.93M	7.58M	7.71M	7.52M	7.52M	7.3M	7.04M	6.6M	6.01M	4.75M	3.84M	4.47M	3.35M	2.23M	1.72M	23K
Research & Development	19.65M	18.58M	18.15M	17.56M	14.61M	13.94M	12.92M	12.69M	14.35M	15.67M	15.38M	15.51M	15.55M	13.79M	13.23M	9.97M	9.61M	11.35M	9.55M	8.4M	4.25M	n/a
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	28.87M	28.27M	27.57M	26.41M	22.97M	21.02M	19.85M	20.26M	22.06M	23.19M	22.9M	22.81M	22.59M	20.39M	19.23M	14.72M	13.45M	15.82M	12.89M	10.63M	5.96M	23K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	28.87M	28.27M	27.57M	26.41M	22.97M	21.02M	19.85M	20.26M	22.06M	23.19M	22.9M	22.81M	22.59M	20.39M	19.23M	14.72M	13.45M	15.82M	12.89M	10.63M	5.96M	23K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	23.48M	23.41M	21.81M	22.72M	21.37M	19.94M	19.5M	17.23M	16.9M	16.56M	17.42M	16.1M	15.18M	14.72M	14.64M	14.05M	12.72M	12.72M	12.72M	12.72M	12.72M	12.72M
Shares Outstanding (Diluted)	23.48M	23.41M	21.81M	22.72M	21.37M	19.94M	19.5M	17.23M	16.9M	16.56M	17.42M	16.1M	15.18M	14.72M	14.64M	14.05M	12.72M	12.72M	12.72M	12.72M	12.72M	12.72M
EPS (Basic)	-1.31	-1.31	-1.32	-1.35	-1.15	-1.11	-1.09	-1.17	-1.30	-1.42	-1.44	-1.52	-1.57	-1.47	-1.52	-1.23	-1.20	-1.39	-1.07	-0.86	-0.47	0
EPS (Diluted)	-1.31	-1.31	-1.32	-1.35	-1.15	-1.11	-1.09	-1.17	-1.30	-1.42	-1.44	-1.52	-1.57	-1.47	-1.52	-1.23	-1.20	-1.39	-1.07	-0.86	-0.47	0
EBITDA	-28.92M	-28.06M	-27.34M	-25.38M	-22.07M	-20.16M	-19M	-19.37M	-21.1M	-22.38M	-22.26M	-22.33M	-22.33M	-20.19M	-19.09M	-14.65M	-13.44M	-15.81M	-12.89M	-10.63M	-5.96M	-23K
EBIT	-28.92M	-28.06M	-27.34M	-25.38M	-22.07M	-20.16M	-19M	-19.37M	-21.1M	-22.38M	-22.26M	-22.33M	-22.33M	-20.19M	-19.09M	-14.65M	-13.44M	-15.81M	-12.89M	-10.63M	-5.96M	-23K
Depreciation & Amortization	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a